Trial Profile
A Phase II Trial of BBR 2778 in Combination With Cytarabine, Methylprednisolone and Cisplatin (BSHAP) as Salvage in Patients With Relapsed Aggressive Non-Hodgkin's Lymphoma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Cytarabine (Primary) ; Filgrastim (Primary) ; Methylprednisolone (Primary) ; Pixantrone (Primary) ; Rituximab (Primary)
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 24 Sep 2005 New trial record.